These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 888120)

  • 1. Formation and dissociation of soluble fibrin in vivo.
    Mahn I; Schönbach F; Müller-Berghaus G
    Thromb Res; 1977 Jul; 11(1):67-80. PubMed ID: 888120
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo behaviour of homologous urea-soluble 131I-fibrin and 125I-fibrinogen in rabbits: the effect of fibrinolysis inhibition.
    Müller-Berghaus G; Mahn I; Köveker G; Maul FD
    Br J Haematol; 1976 May; 33(1):61-79. PubMed ID: 1268091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 4. The fate of soluble fibrin monomer in relation to intravascular fibrin formation and degradation in rabbits.
    Gurewich V; Wetmore R; Nowak A; Lipinski B
    Blood; 1974 Nov; 44(5):723-33. PubMed ID: 4420440
    [No Abstract]   [Full Text] [Related]  

  • 5. Gel filtration of 125I-fibrin and 131I-fibrinogen at 20 degrees C and 37 degrees C.
    Krell W; Mahn I; Müller-Berghaus G
    Thromb Res; 1979; 14(2-3):299-310. PubMed ID: 442008
    [No Abstract]   [Full Text] [Related]  

  • 6. Incorporation of 125 I-fibrinogen in circulating soluble fibrin monomer complexes during hypercoagulability.
    von Hugo R; Hafter R; Stein B; Stemberger A; Rjosk H; Graeff H
    Thromb Res; 1977 May; 10(5):703-10. PubMed ID: 329464
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation and dissociation of soluble fibrin complexes in plasma at 20 degrees C and at 37 degrees C.
    Müller-Berghaus G; Mahn I; Krell W
    Thromb Res; 1979; 14(4-5):561-72. PubMed ID: 483255
    [No Abstract]   [Full Text] [Related]  

  • 8. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation and detection of fibrinogen derived complexes.
    Latallo ZS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of heparin and dipyridamole on the deposition of fibrin-like material in rabbits infused with soluble fibrin monomer or fibrinogen.
    Lipinski B; Gurewich V; Nowak A; Wetmore R
    Thromb Res; 1974 Sep; 5(3):343-58. PubMed ID: 4439374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Continuous measurement of lysis of radioactively marked fibrin clots].
    Koth W; Klöcking HP; Seeck W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):870-6. PubMed ID: 6083964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes.
    Brosstad F
    Thromb Res; 1979; 15(3-4):563-8. PubMed ID: 40318
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 15. The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen-fibrin degradation products and fibrin monomer.
    Gurewich V; Hume M; Patrick M
    Chest; 1973 Nov; 64(5):585-90. PubMed ID: 4750329
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral contraceptives and increased formation of soluble fibrin.
    Pilgeram LO; Ellison J; Von dem Bussche G
    Br Med J; 1974 Aug; 3(5930):556-8. PubMed ID: 4414937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum-induced defect in fibrin formation.
    Deykin D; Silversmith P; Ashford T
    J Lab Clin Med; 1970 Nov; 76(5):761-74. PubMed ID: 4249037
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 19. Major operations, hemostatic parameters and venous thrombosis.
    Korvald E; Abildgaard U; Fagerhol MK
    Thromb Res; 1974 Jan; 4(1):147-54. PubMed ID: 4829665
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.